We offer complimentary consultations to assess your concerns and recommend the safest, most effective path forward
suitable In-vitro release pattern was obtained wherein even with lower doses, one can deliver sufficient GHK-Cu so that at least 100 micrograms, prefearably 200 micrograms and most preferably 300 micrograms of GHK-Cu remain at the end of 24 hrs
Tirzepatide is a 39amino acid dual incretin receptor agonist that activates both GLP1 and GIP receptors, enhancing glucosedependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2]
It protects the liver and helps detoxify the liver and cells, detoxifies from heavy metals, is a powerful antioxidant and combines with selenium to form the enzyme glutathione peroxidase
more Yadiiti
No qualified dermatologist on premises